Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence

Blood

Volumn 117, Issue 4, 2011, Pages 1156-1166

  Cho, Joonseok ^a,b   Shen, Hongmei ^c   Yu, Hui ^b   Li, Hongjie ^d   Cheng, Tao ^a,b,e   Lee, Sean Bong ^d   Lee, Byeong Chel ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; RNA BINDING PROTEIN EWS;

AGING; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EWING SARCOMA; GENOTYPE; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE;

EID: 79251557792     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-279349     Document Type: Article

References (48)

1. Meltzer PS. Is Ewing's sarcoma a stem cell tumor? Cell Stem Cell. 2007;1(1):13-15.
2. Bertolotti A, Bell B, Tora L. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene. 1999;18(56): 8000-8010. (Pubitemid 30050561)
3. Torchia EC, Boyd K, Rehg JE, Qu C, Baker SJ. EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice. Mol Cell Biol. 2007; 27(22):7918-7934.
4. Matsunobu T, Tanaka K, Nakamura T, et al. The possible role of EWS-Fli1 in evasion of senescence in Ewing's family tumors. Cancer Res. 2006;66(2):803-811.
5. Deneen B, Denny CT. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene. 2001;20(46):6731- 6741.
6. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL Jr. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, Ewing's sarcomalike tumors. Cancer Res. 2005;65(19):8698-8705.
7. Riggi N, Cironi L, Provero P, et al. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 2005;65(24):11459-11468.
8. Codrington R, Pannell R, Forster A, et al. The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells. PLoS Biol. 2005;3(8):e242. (Pubitemid 41205889)
9. Jakovljevic G, Nakic M, Rogosic S, et al. Pre-Bcell acute lymphoblastic leukemia with bulk extramedullary disease and chromosome 22 (EWSR1) rearrangement masquerading as Ewing's sarcoma. Pediatr Blood Cancer. Jan 4 2010.
10. Masjosthusmann K, Bielack SS, Kohler G, et al. Concomitant Ewing's sarcoma and acute lymphoblastic leukemia in a 5-year-old girl. Pediatr Blood Cancer. 2005;45(6):846-849.
11. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature. 2007; 447(7145):725-729.
12. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007;8(9):703-713.
13. Nijnik A, Woodbine L, Marchetti C, et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature. 2007;447(7145):686-690.
14. Li H, Watford W, Li C, et al. Ewing's sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest. 2007;117(5): 1314-1323.
15. Ploemacher RE, van der Sluijs JP, Voerman JS, Brons NH. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 1989;74(8):2755-2763.
16. Shen H, Boyer M, Cheng T. Flow cytometry-based cell cycle measurement of mouse hematopoietic stem and progenitor cells. Methods Mol Biol. 2008;430:77-86.
17. Aman P, Panagopoulos I, Lassen C, et al. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics. 1996;37(1):1-8. (Pubitemid 26341827)
18. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121(7):1109-1121.
19. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007;128(2):325-339.
20. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003;423(6937):302-305.
21. Okada S, Yoshida T, Hong Z, et al. Impairment of B lymphopoiesis in precocious aging (klotho) mice. Int Immunol. 2000;12(6):861-871.
22. van Os R, de Haan G, Dykstra BJ. Hematopoietic stem cell quiescence: yet another role for p53. Cell Stem Cell. 2009;4(1):7-8.
23. Hodgson GS, Bradley TR. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature. 1979;281(5730):381-382.
24. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med. 1996;2(9):1011-1016.
25. Van Zant G, Liang Y. The role of stem cells in aging. Exp Hematol. 2003;31(8):659-672.
26. Rossi DJ, Bryder D, Weissman IL. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol. 2007;42(5):385-390.
27. Sudo K, Ema H, Morita Y, Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med. 2000;192(9):1273-1280.
28. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev. 1998; 102(2-3):199-209.
29. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211(2): 144-156.
30. Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol. 2004;172(6):3437-3446.
31. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273(10):5858-5868.
32. Kamminga LM, Bystrykh LV, de Boer A, et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood. 2006;107(5): 2170-2179.
33. Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006;443(7110):421-426. (Pubitemid 44477274)
34. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/ waf1. Science. 2000;287(5459):1804-1808.
35. Douglas D, Hsu JH, Hung L, et al. BMI-1 promotes Ewing's sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res. 2008; 68(16):6507-6515.
36. Richter GH, Plehm S, Fasan A, et al. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proc Natl Acad Sci U S A. 2009;106(13):5324-5329.
37. Rando TA. Stem cells, ageing and the quest for immortality. Nature. 2006;441(7097):1080-1086.
38. Song Y, Bahnson A, Hall N, et al. Stem cell traits in long-term co-culture revealed by time-lapse imaging. Leukemia. Oct 1 2009.
39. Rowley JD. Chromosomal translocations: revisited yet again. Blood. 2008;112(6):2183-2189.
40. Riggi N, Suva ML, Suva D, et al. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res. 2008;68(7):2176-2185.
41. Kovar H. Context matters: the hen or egg problem in Ewing's sarcoma. Semin Cancer Biol. 2005;15(3):189-196.
42. Guiter GE, Gamboni MM, Zakowski MF. The cytology of extraskeletal Ewing's sarcoma. Cancer. 1999;87(3):141-148.
43. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest. 2004;113(2):160-168.
44. Satyanarayana A, Rudolph KL. p16 and ARF: activation of teenage proteins in old age. J Clin Invest. 2004;114(9):1237-1240.
45. Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med. 2001;193(8):917-924.
46. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A. 1995; 92(11):4818-4822.
47. Kovar H, Jug G, Aryee DN, et al. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing's family of tumors. Oncogene. 1997;15(18):2225-2232.
48. Harrison DE. Potential misinterpretations using models of accelerated aging. J Gerontol. 1994; 49(6):B245-246.